BI-RADS (Breast Imaging-Reporting and Data System) is a risk assessment and quality assurance tool developed by American College of Radiology that provides a widely accepted lexicon and reporting schema for imaging of the breast. It applies to mammography, ultrasound, and MRI. This article reflects the 5th edition, published in 2013 1.
On this page:
Classification
Breast imaging studies are assigned one of seven assessment categories:
-
BI-RADS 0: incomplete
need additional imaging evaluation (additional mammographic views or ultrasound) and/or
for mammography, obtaining previous images not available at the time of reading
-
BI-RADS 1: negative
symmetrical and no masses, architectural distortion, or suspicious calcifications
-
BI-RADS 2: benign
0% probability of malignancy
-
BI-RADS 3: probably benign
<2% probability of malignancy
short interval follow-up suggested
-
BI-RADS 4: suspicious for malignancy
2-95% probability of malignancy
-
for mammography and ultrasound, these can be further divided:
BI-RADS 4A: low suspicion for malignancy (2-9%)
BI-RADS 4B: moderate suspicion for malignancy (10-49%)
BI-RADS 4C: high suspicion for malignancy (50-94%)
biopsy should be considered
-
BI-RADS 5: highly suggestive of malignancy
>95% probability of malignancy
appropriate action should be taken
BI-RADS 6: known biopsy-proven malignancy
When there are multiple findings, the BI-RADS category for the exam is assigned the highest category in the following hierarchy, from lowest to highest: 1, 2, 3, 6, 0, 4, 5.
The vast majority of screening mammograms fall into BI-RADS 1 or 2 4. Screening mammograms with suspicious findings should generally be assigned BI-RADS 0 to indicate a callback for diagnostic evaluation, meaning additional views to confirm and further evaluate the finding.
Radiographic appearance
BI-RADS provides standardized terminology to describe breast imaging findings.
Ultrasound
Tissue composition
These terms are only used in screening ultrasounds and not in the diagnostic setting.
homogeneous background echotexture - fat
homogeneous background echotexture - fibroglandular
heterogeneous background echotexture
See main article on breast echotexture.
Masses
-
shape
oval
round
irregular
-
orientation
parallel
not parallel
-
margin
circumscribed
angular
microlobulated
indistinct
spiculated
-
echo pattern (in comparison to subcutaneous fat)
anechoic
hyperechoic
hypoechoic
isoechoic
heterogeneous
complex cystic and solid
-
posterior features
no posterior features
enhancement
shadowing
combined pattern
See main article on breast masses.
Calcifications
calcifications in a mass
calcifications outside of a mass
intraductal calcifications
Associated features
duct changes
-
skin changes
skin thickening
skin retractions
edema
-
vascularity
absent
internal vascularity
vessels in rim
-
elasticity assessment
soft
intermediate
hard
Special cases
mass in or on skin
foreign body including implants
-
vascular abnormalities
arteriovenous malformations/pseudoaneurysms
postsurgical fluid collection
Mammography
Breast composition
fatty: the breasts are almost entirely fatty
scattered fibroglandular: there are scattered areas of fibroglandular density
heterogeneously dense: the breasts are heterogeneously dense, which may obscure small masses
extremely dense: the breasts are extremely dense, which lowers the sensitivity of mammography
See the main article on breast density.
Masses
-
shape
round
oval
irregular
-
margin
circumscribed
obscured
microlobulated
indistinct
spiculated
-
density
high density
equal density
low density
fat-containing
See main article on breast masses.
Calcifications
-
typically benign
-
coarse heterogeneous
fine pleomorphic
fine linear or fine-linear branching
-
distribution
diffuse
regional
grouped
linear
segmental
See main article on breast calcifications.
Other findings
-
asymmetry
focal asymmetry
developing asymmetry
skin lesion
Associated features
skin retraction
nipple retraction
skin thickening
trabecular thickening
calcifications
Location of lesion
laterality
quadrant and clock face
depth
distance from the nipple
MRI
Amount of fibroglandular tissue
almost entirely fat
scattered fibroglandular tissue
heterogeneous fibroglandular tissue
extreme fibroglandular tissue
See the main article on breast density.
Background parenchymal enhancement
-
level
minimal
mild
moderate
marked
-
symmetry
symmetric
asymmetric
See main article on background parenchymal enhancement.
Masses
-
shape
round
oval
irregular
-
margins
circumscribed
irregular
spiculated
-
internal enhancement characteristics
homogeneous
heterogeneous
rim enhancement
dark internal septations
See main article on breast masses.
Non-mass enhancement
-
distribution
focal
linear
segmental
regional
multiple regions
diffuse
-
internal enhancement patterns
homogeneous
heterogeneous
clumped
clustered ring
See main article on non-mass enhancement.
Other findings
skin lesion
ductal precontrast high signal on T1W
cyst
postoperative collections (hematoma/seroma)
post-therapy skin thickening and trabecular thickening
non-enhancing mass
signal void from foreign bodies, clips, etc.
Associated features
nipple retraction
nipple invasion
skin retraction
skin thickening
-
skin invasion
direct invasion
inflammatory cancer
axillary adenopathy
pectoralis muscle invasion
chest wall invasion
Fat-containing lesions
-
normal
postoperative seroma/hematoma with fat
Location of lesion
location
depth
Kinetic curve assessment/signal intensity/time curve description
-
initial phase
slow
medium
fast
-
delayed phase
persistent
plateau
washout
See main article on breast MRI enhancement curves.
Implants
-
implant material and lumen type
saline
-
silicone
intact
other implant material
-
lumen type
single
double
other
-
implant location
retroglandular
retropectoral
-
abnormal implant contour
focal bulge
-
intracapsular silicone findings
-
extracapsular silicone
breast
lymph nodes
water droplets
peri-implant fluid
Radiology report
Findings should be identified in the radiology report if they are suspicious, new, enlarging, or more extensive than at prior exams. Findings should be accompanied by a description of their location and an assessment of suspicion for malignancy.
Treatment and prognosis
When used appropriately, the BI-RADS assessment categories accurately reflect their positive predictive value for cancer, which are on average as follows for mammographically identified lesions that underwent biopsy 3:
BI-RADS 2: 0%
BI-RADS 3: 2%
BI-RADS 4: 30%
BI-RADS 5: 97%
See also
There are other systems for classifying breast lesions: